In the studies described herein, we used our own CD200-/- BALB/c mice and WT BALB/c mice as EMT6 and EMT6siCD200 tumor bearing hosts to investigate how the lack of CD200 expression by host and tumor cells affected EMT6 breast cancer progression. Here, CD200 is linked to breast carcinoma.